Cargando…
Differences between the perspectives of physicians and patients on the potential barriers to optimal diabetes control in China: a multicenter study
BACKGROUND: To investigate the potential barriers to optimal diabetes control by evaluating the different perspectives of physicians and patients on such matters in China. METHODS: This multi-center survey was conducted from December 2015 to March 2016. A multi-stage stratified random sampling metho...
Autores principales: | Liu, Chun, Xu, Shaoyong, Ming, Jie, Jia, Aihua, Wei, Yingji, Li, Hui, Jiao, Yang, Song, Mingxi, Zhao, Yadong, Du, Yafang, Yang, Wenjuan, Lu, Xiaoqiang, Shi, Shengqi, Tong, Hui, Jia, Guangtang, Zhao, Guohua, Wang, Li, Zhang, Mei, Wang, Junlin, Liu, Wenshu, Fang, Lin, Dong, Fuhong, Ji, Qiuhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292153/ https://www.ncbi.nlm.nih.gov/pubmed/30541544 http://dx.doi.org/10.1186/s12913-018-3783-5 |
Ejemplares similares
-
Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial
por: Ming, Jie, et al.
Publicado: (2018) -
Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population: A nationwide study
por: Yu, Xinwen, et al.
Publicado: (2018) -
Normal weight obesity and the risk of diabetes in Chinese people: a 9-year population-based cohort study
por: Xu, Shaoyong, et al.
Publicado: (2021) -
Genomic profiling of WRKY transcription factors and functional analysis of CcWRKY7, CcWRKY29, and CcWRKY32 related to protoberberine alkaloids biosynthesis in Coptis chinensis Franch
por: Huang, Xiaoqiang, et al.
Publicado: (2023) -
Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial
por: Xu, Shaoyong, et al.
Publicado: (2016)